| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
February 11, 2008 |
|
|
| |
|
|
| |
|
|
|
The Center for Professional Advancement, Amsterdam, The Netherlands
2-4 June 2008
Who Should Attend
This overview course is intended for those having specific responsibilities in the areas of sterile drug product science and technology. It will be of particular value to those in:- Research
- Development
- Production
- Quality Assurance and Control
Those who wish to broaden their appreciation of these technologies and review the latest developments, as well as managers who have responsibility for a broader base of activities will find the course of interest. Description
This comprehensive course provides an appreciation and general understanding of the overall contemporary state of science and technology associated with the design, development and manufacturing of sterile drug dosage forms. Emphasis will be oriented toward formulation development and product manufacture of quality sterile dosage forms that meet or exceed expected good manufacturing practice requirements.
|
|
|
|
|
|
|
|
Organized by:
|
|
The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Dr. Michael J. Akers; Senior Director of Pharmaceutical R&D, Baxter BioPharma Solutions
Dr. Michael J. Akers has taught sterile product courses for 30 years. He has 35 years of experience in the development and manufacture of sterile dosage forms including solutions, suspensions, ophthalmics, and freeze dried products. He has contributed to the filing of eleven new drug applications including Humulin® Cartridges and Gemzar®. Currently, Dr. Akers is Senior Director of Pharmaceutical Research and Development for Baxter BioPharma Solutions in Bloomington, IN. Previously, he served as an independent consultant for the parenteral industry with over 60 clients. His background includes significant experiences at Searle (now Pfizer), Alcon, and Eli Lilly. He also was professor of pharmaceutics at the University of Tennessee College of Pharmacy and currently is adjunct professor at six schools of pharmacy. He authored the chapter on Parenteral Products in the 2005 21st edition of Remington's: The Science and Practice of Pharmacy.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
info@cfpa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|